Biotricity, Inc.
BTCY
$0.11
$0.00-2.47%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.79% | -3.79% | -2.81% | 65.28% | -57.48% |
| Total Depreciation and Amortization | 3.34% | -47.25% | 15,026.67% | -98.62% | 3.23% |
| Total Amortization of Deferred Charges | 10.35% | -8.21% | 31.58% | -6.40% | -43.63% |
| Total Other Non-Cash Items | -96.46% | 297.09% | -171.93% | -92.67% | 2,430.00% |
| Change in Net Operating Assets | 93.84% | -166.93% | 7,636.00% | 101.79% | -183.20% |
| Cash from Operations | 97.18% | -278.13% | 211.30% | 6.84% | -354.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -120.20% | 169.54% | -32.43% | -11.16% | -30.30% |
| Total Debt Repaid | 200.00% | 87.17% | -- | -- | -15.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | -- | -- | -- |
| Total Dividends Paid | 0.00% | 1.64% | -3.39% | 3.28% | -3.39% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -112.69% | 242.07% | -216.53% | 164.06% | -61.18% |
| Foreign Exchange rate Adjustments | 117.82% | -455.91% | 125.69% | -114.76% | 258.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -200.00% |
| Net Change in Cash | -104.61% | 37.08% | -417.24% | 118.06% | -142.97% |